Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic counselling for hereditary predisposition to ovarian and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Oct 2010

Mackay J, Szecsei C M

Abstract excerpt

Since the identification of BRCA 1 and 2 in 1995, testing for mutations in these genes has been offered to cancer patients and their families by clinical genetics services. These services are provided across Europe by a small number of health professionals, and are therefore low volume, and low capacity and patients experience considerable delays, both in seeing a clinician and in laboratory testing. The UK...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 20943638
DOI: 10.1093/annonc/mdq365

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic counselling for hereditary predisposition to ovarian and breast cancer.PMID 20943638Read ↗

UK BRCA mutation testing in patients with ovarian cancer.Semantic proximity Read ↗

Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendationsSemantic proximity Read ↗

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.Semantic proximity Read ↗

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer.Semantic proximity Read ↗

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.Semantic proximity Read ↗

Genetic counselling in breast and colorectal cancer.Semantic proximity Read ↗

Current practices on genetic testing in ovarian cancerSemantic proximity Read ↗

Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.Semantic proximity Read ↗

Steering a course around the genetic iceberg.Semantic proximity Read ↗

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.Semantic proximity Read ↗

FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing PracticesSemantic proximity Read ↗

Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.